MANNITOL Inf.-LSG. 20, 10x250 ml

Mannitol infusion solution 20

Supin.: 1 L Cont.: Active ingredient: Mannitol 200 g. Otherwise. Exist.: Water for injections.

REST: Therapy and prophylaxis of acute kidney failure as a result of trauma or shock after previous trial infusion, brain pressure lowering with intact blood-brain barrier, osmotherapy for brain edema prophylaxis and therapy, glaucoma.

Against: Oligurie/anuria after trial infusion, cardiac decompensation, dehydration states, hyperhydration, pulmonary edema, intracranial bleeding, drainage obstacle in the area of the derivative urinary tract, increased serumosmolarity. Pregnancy: There is a risk of overdose after infusion after infusion of large quantities of Mannitol solution as a result of overloading the kidneys in late pregnancy. Next: After quick infusion, nausea, vomiting, upper abdominal pain, headache, states of confusion, cramps and tachycardia can occur. Thrombophlebitis can arise at the injection site. OSMODIURATS like Mannitol can only have their effect if they are applied with a corresponding infusion speed (approx. 125 ml in approx. 20 - 40 minutes). In any case, this is associated with an acute volume load on the organism, which is more serious the lower the urine production. Before the start of osmotherapy with Mannitol, kidney failure as a result of fluid or volume lack. Disruptions in water balance with dehydration, disorders in the electrolyte balance with strong electrolyte loss, formation of pulmonary edema with restricted kidney function, acute kidney failure, hypersensitivity reactions and anaphylactic shock.